Skip to content

Advertisement

  • Case report
  • Open Access
  • Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Extending the ophthalmological phenotype of Galloway-Mowat syndrome with distinct retinal dysfunction: a report and review of ocular findings

BMC Ophthalmology201818:147

https://doi.org/10.1186/s12886-018-0820-4

  • Received: 13 October 2017
  • Accepted: 11 June 2018
  • Published:

Abstract

Background

Galloway-Mowat syndrome (GMS) is a rare autosomal recessive condition first described in 1968 and characterized by microcephaly and infantile onset of central nervous system (CNS) abnormalities resulting in severely delayed psychomotor development, cerebellar atrophy, epilepsy, and ataxia, as well as renal abnormalities such as nephrotic syndrome, proteinuria, end-stage renal disease (ESRD), and hiatal hernia.

Case presentation

We describe a GMS case diagnosed with homozygous missense mutation in the WDR73 gene, with absence of renal abnormalities. We expanded the clinical phenotype of GMS with WDR73 gene defect to include retinal dysfunction with missense mutation and developmental dysplasia of the hip. We compared eye findings of our case to previously reported cases, and we present an electroretinogram (ERG) picture for the first time in the literature.

Conclusion

We recommend that clinicians screen patients with GM syndrome for retinal dysfunction and that a skeletal survey should be done to detect developmental dysplasia of the hip (DDH) so as to provide for early intervention.

Keywords

  • Galloway-Mowat syndrome
  • WDR37
  • Retinal dysfunction
  • Absence of perinatal and neonatal renal dysfunction

Background

Galloway-Mowat syndrome (GMS; OMIM 251300) is a rare autosomal recessive genetic neurodegenerative disorder characterized by a classical triad of central nervous system (CNS) abnormalities, including infantile onset of microcephaly, cerebellar atrophy, epilepsy, ataxia, delayed psychomotor development, renal abnormalities (nephrotic syndrome, proteinuria, and end stage renal disease or ESRD), and hiatal hernia. However, hiatal hernia is not an essential sign for diagnosis [1].

Since 1968, approximately 80 GMS cases have been reported, resulting in significant expansion of the heterogeneity of the clinical features to now exclude hiatal hernia [2]. Subsequently, GMS cases were recognized in the absence of renal involvement [3]. As a result of this clinical variability, the syndrome was thought to be genetically heterogeneous. A number of genes were implicated until the WDR73 gene was mapped to chromosome 15q24-q26 in a family that presented with GMS clinical features [4, 5]. Thereafter, WDR73 mutations were identified as the causative mutations for GMS using Sanger sequencing and whole exome sequencing (WES) [1, 68]. Furthermore, the role of WDR73 in neurodevelopment has been shown by gene expression and loss of function studies carried out in the zebrafish model system [8]. The WRD73 gene encodes a multiple WD40 repeats protein with motifs that contain 40–60 amino acids. WD40 proteins function as protein-protein interaction adaptors; these interchangeable substrate receptors target different substrates selectively, provide for signal transduction, transcription regulation for cell cycle control, autophagy, and apoptosis in several different cellular processes [9]. WDR73 protein is expressed in brain and kidney tissue and plays a crucial role in the maintenance of cell architecture and survival [1, 6]. In comparison to GMS cases with negative WDR73-mutations, GMS patients with WDR73-mutations present with classical GMS clinical features including cerebellar atrophy, thin corpus callosum, brain-stem hypoplasia, occasional coarse face, late-onset and mostly slow progressive nephrotic syndrome. Frequent epileptic symptoms were limited to WDR73-positive mutation patients but hiatal hernia was absent in this group [8]. The ophthalmological findings associated with GMS include optic atrophy, nystagmus, strabismus, oculomotor apraxia, myopia, microphthalmia, and corneal opacities [1, 68]. Retinal involvement has not been described previously [1].

In the present report, we describe a 41-month-old Saudi female who was diagnosed with GMS that was confirmed by finding a known homozygous missense mutation in the WDR73 gene. Additionally, we expanded the clinical features of GMS with WDR73-mutation to include retinal dysfunction with the missense mutation. We compared eye findings of our case to previously reported cases and present an electroretinogram (ERG) for the first time in the literature.

Case presentation

A Saudi female infant was delivered by C-section after pre-term labor at 32 weeks. She was a product of in vitro fertilization (IVF) from first-cousin healthy parents, and had a birth weight of 1085 g (<3rd percentile), a length of 46 cm (85th percentile), and a head circumference of 31.5 cm (75th percentile), She had a healthy twin brother and a healthy elder sister. Neonatal examination showed that the patient was active, moving all 4 limbs, and that her primitive reflexes were positive. She was admitted to the intermediate care nursery (ICN) for 17 days for respiratory distress syndrome (RDS) and prematurity.

At the age of 18 months, the patient was presented to our genetics clinic for global developmental delay corresponding to an age of 3 months, hypotonia, upward posture of the big toe, and overlapping 1st and 2nd toes bilaterally. In addition, she had poor vision and evidence of delayed myelination on neuroimaging.

At 22 months of age, she could not visually track or fix, sit, grasp, or creep, and she demanded prolonged feeding but did not choke. She had strabismus, horizontal nystagmus, and persistent axial hypotonia. She had abdominal distention with no organomegaly. The right hip demonstrated features of developmental dysplasia of the hip (DDH) with a shallow acetabular roof, a smaller right femoral epiphysis than on the left side, and a dislocated hip with frog like posture of the legs. She responded to sound and appreciated light to her eyes. She had mild to moderate disc pallor and optic atrophy, with visual evoked responses (VER) and ERGs suggesting significant retinal dysfunction (Fig. 1). Magnetic resonance imaging (MRI) revealed high signal intensities of the white matter bilaterally that related to delayed myelination.
Figure 1
Fig. 1

Combined assessment of the patient eyes obtained via electroretinogram (ERG) and visual evoked responses (VER) tests: The upper tracing is a flash ERG (25 ms) stimulus that shows a poorly-formed low amplitude b-wave, and the other tracings below are flash VER with reproducible positive waves at about 100 ms (P100) upon stimulation of either eye. These findings are suggestive of significant retinal dysfunction

Developmentally, at the age of 41 months she had a momentary head control. However, she could not grasp, her fist was open at all times, and she could not fix or follow or sit without support. She had no speech but socially she was able to laugh and smile. Developmentally, she was functioning at the level of a 3-month-old child. On examination, we observed dysmorphic features (i.e., hypertelorism, ptosis, epicanthal folds, micrognathia, long eye lashes and hirsutism, microcephaly, generalized hypotonia, global developmental delays, and impaired vision. Of note, her BUN levels ranged between 0.7 and 3.5 mmol/l (2.5–6) while those of creatinine ranged between 30 and 57 umol/l (27–62), and albumin was 30 g/l >(28–44). All were within normal ranges, with no proteinuria. There were normal urine magnesium levels and protein/creatinine ratios. Extensive laboratory investigations showed normal female karyotype, acylcarnitine profile, plasma amino acids, urinary organic acids, carbohydrate-deficient transferrin (CDT) levels, and very long chain fatty acids (VLCFA), oligosaccharides and mucopolysaccharides. The comparative genomic hybridization (CGH) microarray and DNA molecular testing for SMN1 gene were unremarkable. Therefore, aminoacidopathies, organic acidemia, fatty acid oxidation defects, congenital disorder of glycosylation, peroxisomal disorders, oligosaccharidosis, and mucopolysaccharidosis were unlikely.

Whole-exome sequencing (WES) revealed that she had a previously described homozygous mutation in the WDR73 gene [NM_032856.3, c.287G > A (p. Arg96Lys)] which segregated well with the family as the parents and her sister were heterozygous for the same mutation [1].

Discussion

Table 1 summarizes the ophthalmological findings of GMS. The most common eye abnormalities are optic atrophy (70%), followed by nystagmus (49%) and strabismus (16%), respectively. Hypertelorism and epicanthal folds are present in 8% of the cases, and ptosis, oculomotor apraxia, and microphthalmia occur in approximately 4%. Other rare anomalies include retinopathy, hypoplastic changes of the iris, and corneal opacification.
Table 1

Ophthalmological findings of patients with Galloway-Mowat Syndrome [18, 1013, 1517]

Clinical feature

Number of affected (total: 76)

%

Optic atrophy

53

70%

Nystagmus

37

49%

Strabismus

12

16%

Hypertelorism

7

8%

Epicanthal folds

7

8%

Ptosis

3

4%

Oculomotor apraxia

3

4%

Microphthalmia

3

4%

Retinopathy

3

4%

Hypoplasia of the iris

1

1.3%

Corneal opacification

1

1.3%

In their original report of this syndrome in 1968, Galloway and Mowat described two siblings (one boy, one girl) who suffered from microcephaly, hiatal hernia, and nephrotic syndrome [10]. However, there were no ophthalmologic findings in this family. Subsequently, a series of cases were reported with eye findings [1, 2, 48].

Of note, retinopathy was reported previously in association with the c.400_401delAG, p.(Trp136Alafs*2) mutation in the WDR73 gene [1]. However, we are unaware of any other reports of retinal dysfunction in GMS with a c.287G > A (p. Arg96Lys) WDR73-mutation and we delineated the retinal dysfunction phenotype further with ERG (Fig. 1), which showed poorly formed low-amplitude b-waves suggestive of retinal dysfunction. Diagnosis of retinal abnormalities could have been missed previously as several patients died within the first years of life and their visual impairment might have been attributed to optic atrophy, which is a common finding [1].

The mechanisms for the ocular features of this syndrome have not been fully defined. WDR73 gene expression was highest in the cerebellar cortex, with lesser expression in other brain regions including the neocortex. Additionally, it was expressed in renal glomeruli [1, 6]. WDR73 mutations may cause disruption in mitosis by interfering with spindle functions [7, 11], which can lead to brain anomalies including ocular lesions. However, such conclusions are hypothetical and functional studies should be done in order to delineate the mechanisms of the ocular findings and other clinical features of this syndrome.

Interestingly, the patient did not have perinatal renal dysfunction or a hiatal hernia, corroborating previous reports [1, 3, 8, 12]. Nonetheless, these features could develop later. In addition, the patient suffered from DDH with a shallow acetabular roof. This finding is novel and not previously described but could be explained by hypotonia. The reported skeletal features of GMS include joint contractures, talipes equinovarus (clubfoot), and camptodactyly [6, 13]. The present case did not manifest these features.

Brain and CNS anomalies are predominant in GMS, and include psychomotor retardation in the form of lack of speech and non-communication, not fixing or following, delayed milestones (90%); hypotonia (80%); microcephaly (80%); and epilepsy (40%) [1, 6, 11]. Other features include ataxia and dystonia [4, 5]. Of note, our patient was severely developmentally delayed and at 3.5 years of age functioned at the level of a 3-month-old infant. Additionally, she had poor white matter myelination on her brain MRI studies. Other possible radiological findings included brain atrophy, with cerebellar and basal ganglia involvement, gyration defects, hypomyelination, a thin corpus callosum, and Dandy-Walker malformation [1, 68, 10].

GMS is clinically and genetically heterogeneous. The age of diagnosis has varied from 19 days to 31 years. Most affected individuals died in their teenage years, with common causes of death being nephrotic syndrome and renal failure [7, 11]. Our patient is alive at 41 months, and does not have renal manifestations yet.

There is no genotype-phenotype correlation. All types of mutations have been reported including missense, non-sense, and frameshift deletions [1, 8]. Braun et al. [14] reported a complete list of mutations in 4 genes in OSGEP, TP53RK, TPRKB, or LAGE3, encoding the 4 subunits of the KEOPS complex in 33 probands of 30 families with GMS with nephrotic syndrome and primary microcephaly. The findings of microcephaly, reduced gyration, and diffuse cortical atrophy may explain the ocular findings in these patients [14].

Conclusions

In summary, we delineated retinal dysfunction associated with missense mutation supported by ERG findings. Additionally, we described DDH with a shallow acetabular roof as a novel finding in GMS. We suggest that clinicians should screen any patient with GMS for retinal dysfunction, and that a skeletal survey should be done to evaluate for presence of DDH, which if present can benefit from early intervention. Finally, the treatment for this syndrome is supportive and counseling of the parents has to be performed very carefully to avoid raising false hopes.

Abbreviations

CDT: 

Carbohydrate deficient transferrin

CNS: 

Central nervous system

DDH: 

Developmental dysplasia of the hip

ERG: 

Electroretinogram

ESRD: 

End stage renal disease

GMS: 

Galloway-Mowat syndrome

ICN: 

Intermediate care nursery

IVF: 

In vitro fertilization

MRI: 

Magnetic resonance imaging

RDS: 

Respiratory distress syndrome

SMA: 

Spinal muscular atrophy

TMS: 

Tandem mass spectrometry

VER: 

Visual evoked response

VLCFA: 

Very long chain fatty acids

WES: 

Whole exome sequencing

Declarations

Acknowledgments

We are grateful to the patient and her family reported in this article for their support.

Authors’ contributions

MAR: writing the first draft and editing the subsequent versions. MAT: collecting the clinical data and editing the manuscript, MTR: reviewing the electroretinogram and editing the manuscript. MAF prepared and wrote the second draft, submitted the manuscript and contributed to the clinical diagnosis and management of the patient. All authors have read and approved the manuscript.

Ethics approval and consent to participate

This study was approved by the Institutional Review Board at King Abdullah International Medical Research Centre (KIMARC) (Study number: RC16/113/R).

Consent for publication

Written informed consent was obtained from the parents.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Deapartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia
(2)
Division of Neurology, Department of Pediatrics, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Centre, King Abdullah Specialized Children’s Hospital, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs (NGHA), Riyadh, Saudi Arabia
(3)
Division of Genetics, Department of Pediatrics, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Centre, King Abdullah Specialized Children Hospital, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs (NGHA), Riyadh, Saudi Arabia

References

  1. Vodopiutz J, Seidl R, Prayer D, et al. WDR73 mutations cause infantile neurodegeneration and variable glomerular kidney disease. Hum Mutat. 2015;36(11):1021–8.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Ekstrand JJ, Friedman AL, Stafstrom CE. Galloway-Mowat syndrome: neurologic features in two sibling pairs. Pediatr Neurol. 2012;47(2):129–32.View ArticlePubMedGoogle Scholar
  3. Meyers KE, Kaplan P, Kaplan BS. Nephrotic syndrome, microcephaly, and developmental delay: three separate syndromes. Am J Med Genet. 1999;82(3):257–60.View ArticlePubMedGoogle Scholar
  4. Megarbane A, Delague V, Ruchoux MM, et al. New autosomal recessive cerebellar ataxia disorder in a large inbred Lebanese family. Am J Med Genet. 2001;101(2):135–41.View ArticlePubMedGoogle Scholar
  5. Delague V, Bareil C, Bouvagnet P, et al. A new autosomal recessive non-progressive congenital cerebellar ataxia associated with mental retardation, optic atrophy, and skin abnormalities (CAMOS) maps to chromosome 15q24-q26 in a large consanguineous Lebanese Druze family. Neurogenetics. 2002;4(1):23–7.View ArticlePubMedGoogle Scholar
  6. Ben-Omran T, Fahiminiya S, Sorfazlian N, et al. Nonsense mutation in the WDR73 gene is associated with Galloway-Mowat syndrome. J Med Genet. 2015;52(6):381–90.View ArticlePubMedGoogle Scholar
  7. Colin E, Huynh Cong E, Mollet G, et al. Loss-of-function mutations in WDR73 are responsible for microcephaly and steroid-resistant nephrotic syndrome: Galloway-Mowat syndrome. Am J Hum Genet. 2014;95(6):637–48.View ArticlePubMedPubMed CentralGoogle Scholar
  8. Rosti RO, Dikoglu E, Zaki MS, et al. Extending the mutation spectrum for Galloway-Mowat syndrome to include homozygous missense mutations in the WDR73 gene. Am J Med Genet A. 2016;170A(4):992–8.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Xu C, Min J. Structure and function of WD40 domain proteins. Protein Cell. 2011;2(3):202–14.View ArticlePubMedPubMed CentralGoogle Scholar
  10. Galloway WH, Mowat AP. Congenital microcephaly with hiatus hernia and nephrotic syndrome in two sibs. J Med Genet. 1968;5(4):319–21.View ArticlePubMedPubMed CentralGoogle Scholar
  11. Jinks RN, Puffenberger EG, Baple E, et al. Recessive nephrocerebellar syndrome on the Galloway-Mowat syndrome spectrum is caused by homozygous protein-truncating mutations of WDR73. Brain. 2015;138(Pt 8):2173–90.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Pezzella M, Yeghiazaryan NS, Veggiotti P, et al. Galloway-Mowat syndrome: an early-onset progressive encephalopathy with intractable epilepsy associated to renal impairment. Two novel cases and review of literature. Seizure. 2010;19(2):132–5.View ArticlePubMedGoogle Scholar
  13. Cooperstone BG, Friedman A, Kaplan BS. Galloway-Mowat syndrome of abnormal gyral patterns and glomerulopathy. Am J Med Genet. 1993;47(2):250–4.View ArticlePubMedGoogle Scholar
  14. Braun DA, Rao J, Mollet G, et al. Mutations in KEOPS-complex genes cause nephrotic syndrome with primary microcephaly. Nat Genet. 2017;49(10):1529–38.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Garty BZ, Eisenstein B, Sandbank J, Kaffe S, Dagan R, Gadoth N. Microcephaly and congenital nephrotic syndrome owing to diffuse mesangial sclerosis: an autosomal recessive syndrome. J Med Genet. 1994;31(2):121–5.View ArticlePubMedPubMed CentralGoogle Scholar
  16. Krishnamurthy S, Rajesh NG, Ramesh A, Zenker M. Infantile nephrotic syndrome with microcephaly and global developmental delay: the Galloway Mowat syndrome. Indian J Pediatr. 2012;79(8):1087–90.View ArticlePubMedGoogle Scholar
  17. Steiss JO, Gross S, Neubauer BA, Hahn A. Late-onset nephrotic syndrome and severe cerebellar atrophy in Galloway-Mowat syndrome. Neuropediatrics. 2005;36(5):332–5.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2018

Advertisement